[REVISION HISTORY]
US Medicare Part D subsidy termination and cost shifts
Updated 2 times since CLSTR started tracking revisions of this situation.
What changed
2026-08-12 22:49 UTC → 2026-08-23 11:25 UTC ·
added
removed
US Medicare Part D subsidy termination and cost shifts
In late July 2026, the Centers for Medicare & Medicaid Services (CMS) announced that the temporary premium subsidy for Medicare Part D, introduced in 2024, will be discontinued in 2027. The program, which lowered premiums for approximately 25 million seniors and cost roughly $3.6 billion in 2026, was defended by CMS Administrator Dr. Mehmet Ozon as a measure to curb taxpayer spending. He stated that ending the program would prevent billions of dollars from flowing to insurers and predicted that most beneficiaries would see a premium increase of less than $10 per month. Democratic leaders, including Senate Minority Leader Chuck Schumer, criticized the move, with some characterizing it as a politically motivated effort to raise drug costs for seniors. While the decision does not affect out-of-pocket spending caps, officials warned of potential financial impacts on older adults. By mid-August 2026, the administration indicated confirmed it would end the Part D Premium Stabilization Demonstration program one year earlier than originally planned, concluding it after 2026. Dr. Ozon noted this move is intended 2026 to save nearly $4 billion. While some beneficiaries might see decreased premiums, experts warned that early New projections suggest this termination could lead increase premiums by up to higher monthly payments $20 per month for others, particularly those with limited income, as up to 25 million recipients. In response, New York officials, including Governor Kathy Hochul and Senator Kirsten Gillibrand, urged a reversal, warning that 1.3 million seniors in the state could face higher costs. Beyond the subsidy expiration, the 2027 Annual Enrollment Period faces additional pressure from rising medical costs and an aging population. Analysts also warn that the Inflation Reduction Act’s drug price negotiation program might inadvertently lead insurers adjust to recent legislative changes. implement stricter utilization-management tools, such as prior authorization and formulary exclusions, potentially impacting medication access.
Versions
- 2026-08-23 11:25 UTC US Medicare Part D subsidy termination and cost shifts
- 2026-08-12 22:49 UTC US Medicare Part D subsidy termination
- 2026-08-06 23:13 UTC US Medicare Part D subsidy termination
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.